血管通路策略对院外心脏骤停患者长期结局的影响:一项随机临床试验
IVIO试验是一项随机临床试验,比较院外心脏骤停初始骨内与静脉血管通路策略的6个月和1年结局。纳入1479例成人非创伤性院外心脏骤停且需要血管通路的患者,随机分配至初始骨内或静脉通路,分配方法最多尝试两次。1年时骨内组82例(11%)存活,静脉组68例(9%)存活(风险比1.24;95%置信区间0.91-1.67);神经功能良好存活分别为76例(10%)和61例(8%)(风险比1.28;95%置信区间0.93-1.77)。存活者中骨内组平均EQ-5D-5L评分为83,静脉组为76(平均差7;95%置信区间1-13)。结论认为两种血管通路策略的长期结局相似。
要点
- 成人非创伤性院外心脏骤停中,初始骨内通路与静脉通路的1年生存率分别为11%和9%(风险比1.24;95%置信区间0.91-1.67),未达统计学显著。
- 1年神经功能良好存活(改良Rankin量表0-3分)骨内组10% vs 静脉组8%(风险比1.28;95%置信区间0.93-1.77),未达统计学显著。
- 存活者中骨内组平均EQ-5D-5L评分为83,静脉组为76(平均差7;95%置信区间1-13)。
- 分配的通路方法最多尝试两次,两种策略长期结局相似,不支持两者存在差异。
适用人群与场景
- 成人非创伤性院外心脏骤停且需要血管通路的患者。
处置流程与药物剂量
- 随机分配至初始骨内或静脉通路,分配的方法最多尝试两次。
研究设计与关键结果
- IVIO试验为随机临床试验,纳入1479例成人非创伤性院外心脏骤停患者,随机分配至初始骨内或静脉通路,分配方法最多尝试两次。
- 1年生存:骨内组82例(11%)vs 静脉组68例(9%),风险比1.24(95%置信区间0.91-1.67)。
- 1年神经功能良好存活(改良Rankin量表0-3分):骨内组76例(10%)vs 静脉组61例(8%),风险比1.28(95%置信区间0.93-1.77)。
- 存活者平均EQ-5D-5L评分:骨内组83 vs 静脉组76,平均差7(95%置信区间1-13)。
- 1479例中3例失访1年生存。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,长期结局在初始骨内与静脉通路患者中相似,这些发现不支持两种血管通路策略之间存在患者结局差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: The Intravenous versus Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial was a randomised clinical trial that investigated initial vascular access strategy for out-of-hospital cardiac arrest. The current manuscript presents outcomes at 6 months and 1 year.
METHODS: Adults with non-traumatic out-of-hospital cardiac arrest, in whom vascular access was indicated, were randomised to initial intraosseous or intravenous access. The allocated method was attempted up to two times. Prespecified 6-months and 1-year outcomes included survival, survival with a favourable neurological outcome, defined as a modified Rankin Scale score of 0-3, and health-related quality-of-life assessed using the EuroQoL 5-Dimension 5-Level questionnaire on domains of mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
RESULTS: Of the 1479 patients included in the main manuscript primary analyses, three were lost to follow-up for 1-year survival. At 1 year, 82 patients (11%) in the intraosseous group and 68 patients (9%) in the intravenous group were alive (risk ratio 1.24; 95% confidence interval 0.91-1.67). Survival with a favourable neurological outcome was observed in 76 patients (10%) and 61 patients (8%), respectively (risk ratio 1.28; 95% confidence interval 0.93-1.77). Among survivors, the mean EQ-5D-5L numeric score was 83 in the intraosseous group and 76 in the intravenous group (mean difference 7; 95% confidence interval 1-13).
CONCLUSION: Long-term outcomes were similar between patients who received initial intraosseous versus intravenous vascular access during adult out-of-hospital cardiac arrest. These findings do not support a difference in patient outcomes between the two vascular access strategies.
TRIAL REGISTRATION: EU Clinical Trials number 2022-500744-38-00; ClinicalTrials.gov number NCT05205031.
参考来源
- Vallentin MF, Holmberg MJ, Granfeldt A, et al. Effect of vascular access strategy on long-term outcomes in patients with out-of-hospital cardiac arrest: a randomised clinical trial. Resuscitation. 2026. PMID: 41967754. doi:10.1016/j.resuscitation.2026.111087
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。